Birmingham, West Midlands -- (SBWIRE) -- 10/09/2013 -- Value Penny Stocks issues special report on Spindle Inc(OTCMKTS:SPDL) , Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Advanced Cell Technology, Inc.(OTCMKTS:ACTC) , Invivo Therapeutics Holdings Corp(OTCMKTS:NVIV)
Spindle Inc(OTCMKTS:SPDL) managed to keep its gain at 19.05% on above-normal volume of 426,087.00 shares. The stock settled at $1.50 after floating in a range of $1.30 to $1.90. Its latest price was $1.50, reaching market capitalization of $38.46 million. Its 52-week range has been $0.31 to $3.00. Spindle, Inc. provides a mobile commerce platform for consumers and merchants. The company offers the platform for the secure movement of funds between parties and the requisite conversion tools for brands, merchants, and partners to deliver mobile commerce ecosystem.
What was the Moving Force behind SPDL On Bullish Run? Read This Research Report on SPDL
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) traded up on a volume of 713,884.00, higher than its standard daily volume. Shares have gained 2.59% to $0.949. Over the last twelve months, the stock has added 54.31% and faced a best price of $1.14. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis; and PH-10, a Phase IIc randomized study initiated drug candidate for the treatment of psoriasis, and Phase II study completed candidate for atopic dermatitis.
For How Long PVCT will Fight for Profitability? Read This Trend Analysis report
Advanced Cell Technology, Inc.(OTCMKTS:ACTC) settled -0.70% lower at $0.0705 on below-normal volume of 7.64 million shares during the last trading day. The stock has its 12-month high at $0.10 and 52-week low price was $0.05. It traded in a range of $0.07 to $0.07 during the last trading day. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine
Why Should Investors Buy ACTC After the Recent Fall ? Just Go Here and Find Out
Invivo Therapeutics Holdings Corp(OTCMKTS:NVIV) saw its price gain on below-normal volume, as 254,309.00 shares changed hands when compared with its average daily volume of 1.16 million shares. The stock was up 3.60% to $1.44. It has gained over the last 12 months, increasing 5.11% and marked new low $0.94. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)